Shetron Limited (BOM:526137)

Verve Therapeutics Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 25, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	1,401	1,194	920	479	414	178
Market Cap Growth	29.81%	29.81%	92.16%	15.57%	132.91%	35.79%
Enterprise Value	1,761	1,688	1,486	1,127	1,120	779
Last Close Price	155.60	132.60	101.32	52.39	44.90	19.28
PE Ratio	45.50	38.76	14.08	7.98	8.09	-
PS Ratio	0.61	0.52	0.38	0.20	0.18	0.10
PB Ratio	2.39	2.04	1.63	0.95	0.92	0.45
P/TBV Ratio	2.49	2.12	1.70	1.00	0.97	0.47
P/FCF Ratio	5.02	4.27	20.04	-	10.18	-
P/OCF Ratio	4.00	3.41	7.89	4.34	6.12	-
EV/Sales Ratio	0.77	0.74	0.62	0.46	0.49	0.45
EV/EBITDA Ratio	9.20	8.82	6.23	4.75	4.86	5.79
EV/EBIT Ratio	13.60	13.04	8.37	6.15	6.39	9.77
EV/FCF Ratio	6.31	6.05	32.37	-	27.51	-
Debt / Equity Ratio	0.71	0.71	1.15	1.35	1.45	1.90
Debt / EBITDA Ratio	2.19	2.19	2.71	2.87	2.83	5.63
Debt / FCF Ratio	1.50	1.50	14.09	-	16.01	-
Asset Turnover	1.49	1.49	1.56	1.62	1.51	1.15
Inventory Turnover	3.11	3.11	3.62	3.63	3.37	2.92
Quick Ratio	0.49	0.49	0.42	0.42	0.37	0.39
Current Ratio	1.29	1.29	1.47	1.49	1.42	1.42
Return on Equity (ROE)	5.35%	5.35%	12.23%	12.61%	12.09%	-4.83%
Return on Assets (ROA)	5.24%	5.24%	7.22%	7.55%	7.30%	3.35%
Return on Capital (ROIC)	7.30%	7.30%	9.26%	10.02%	9.71%	4.24%
Return on Capital Employed (ROCE)	17.80%	17.80%	21.00%	22.20%	23.10%	10.50%
Earnings Yield	2.20%	2.58%	7.10%	12.54%	12.36%	-11.13%
FCF Yield	19.94%	23.39%	4.99%	-0.69%	9.83%	-11.25%
Dividend Yield	0.64%	0.75%	0.99%	1.91%	-	-
Payout Ratio	29.22%	29.22%	6.89%	7.50%	-	-
Buyback Yield / Dilution	-0.13%	-0.13%	0.01%	3.90%	-14.40%	29.34%
Total Shareholder Return	0.53%	0.63%	1.00%	5.80%	-14.40%	29.34%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.